title: Excess urate excretion correlates with severely acidic urine in patients with renal hypouricemia.
abstract: We evaluated the renal handling of urate in 12 Japanese renal hypouricemia patients, and studied the relationship between the renal handling of urate and the urinary pH. The patients were classified into the 4 subtypes of renal hypouricemia: (defective presecretory reabsorption (Pre), defective postsecretory reabsorption (Post), enhanced tubular secretion (Secretion), and defective presecretory and postsecretory reabsorption (Pre&Post) as based on a pharmacological test. Seven patients showed acid urine with a urinary pH of less than 5.9, although this was not accompanied by any abnormality of blood pH, partial pressure of carbon dioxide (PaCO2), or blood HCO3-. The urinary pH in the morning significantly correlated with the ratio of urate clearance to creatinine clearance in the morning, whereas the urinary urate concentration in the morning did not correlate with the urinary pH in the morning. In the Pre&Post patients, the urate excretion was higher and the urinary pH was more acidic compared to the other subtypes. The administration of K+-, Na+-citrate significantly alkalized the urinary pH in the patients with renal hypouricemia. These results suggest that the acidic urine was significantly related to the Pre&Post subtype of renal hypouricemia with the higher urate excretion, and that this subtype might be a risk factor for complications in renal hypouricemia. The alkalization of urine might be a useful treatment for the complication of renal hypouricemia.
authors.affiliation: First Department of Internal Medicine, Tottori University Faculty of Medicine, Yonago.
authors.forename: I
authors.initials: I
authors.lastname: Hisatome
authors.forename: Y
authors.initials: Y
authors.lastname: Tanaka
authors.forename: M
authors.initials: M
authors.lastname: Tsuboi
authors.forename: T
authors.initials: T
authors.lastname: Yatsuhashi
authors.forename: K
authors.initials: K
authors.lastname: Ogino
authors.forename: T
authors.initials: T
authors.lastname: Uchida
authors.forename: Y
authors.initials: Y
authors.lastname: Yamanouchi
authors.forename: M
authors.initials: M
authors.lastname: Shimoyama
authors.forename: S
authors.initials: S
authors.lastname: Fujita
authors.forename: T
authors.initials: T
authors.lastname: Kinugawa
authors.forename: O
authors.initials: O
authors.lastname: Igawa
authors.forename: A
authors.initials: A
authors.lastname: Yoshida
authors.forename: A
authors.initials: A
authors.lastname: Takeda
authors.forename: R
authors.initials: R
authors.lastname: Sato
authors.forename: C
authors.initials: C
authors.lastname: Shigemasa
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002951:Citrates / Q000494:pharmacology; D003404:Creatinine / Q000652:urine; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007684:Kidney Tubules / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D019357:Potassium Citrate / Q000494:pharmacology; D000077559:Sodium Citrate; D014527:Uric Acid / Q000097:blood / Q000378:metabolism* / Q000652:urine; D014556:Urine / Q000737:chemistry
chemical_list: D002951:Citrates; D000077559:Sodium Citrate; D014527:Uric Acid; D003404:Creatinine; D019357:Potassium Citrate